Rosiglitazone

Revision as of 18:20, 27 September 2011 by WikiBot (talk | contribs) (Protected "Rosiglitazone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Rosigliazone maleate, Rosiglitazone maleate, rosiglitazone, Avandia, Rosiglizole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Monotherapy:
The usual starting dose of AVANDIA is 4 mg administered either as a single dose once daily or in divided doses twice daily. In clinical trials, the 4 mg twice daily regimen resulted in the greatest reduction in FPG and HbA1c.

Combination Therapy:
When AVANDIA is added to existing therapy, the current dose(s) of the agent(s) can be continued upon initiation of AVANDIA therapy.

Sulfonylurea:
When used in combination with sulfonylurea, the usual starting dose of AVANDIA is 4 mg administered as either a single dose once daily or in divided doses twice daily. If patients report hypoglycemia, the dose of the sulfonylurea should be decreased.

For more information on Dosing please refer to Instructions for administration



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Rosiglitazone

Return to top

Publication Resources

Most Recent Articles on Rosiglitazone

Review Articles on Rosiglitazone

Articles on Rosiglitazone in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Rosiglitazone

Return to top

Trial Resources

Ongoing Trials with Rosiglitazone at Clinical Trials.gov

Trial Results with Rosiglitazone

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Rosiglitazone

Cochrane Collaboration on Rosiglitazone

Cost Effectiveness of Rosiglitazone

Return to top

Media Resources

Powerpoint Slides on Rosiglitazone

Images of Rosiglitazone

Podcasts & MP3s on Rosiglitazone

Videos on Rosiglitazone

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Rosiglitazone

Discussion Groups on Rosiglitazone

Patient Handouts on Rosiglitazone

Blogs on Rosiglitazone

Rosiglitazone in the News

Rosiglitazone in the Marketplace

Return to top

International Resources

Rosiglitazone en Español

Return to top


Adapted from the FDA Package Insert.